NRX Pharmaceuticals (NRXP) Depreciation & Amortization (CF) (2020 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Depreciation & Amortization (CF) came in at $63000.0 in Q1 2026, up 6200.0% year-on-year from $1000.0 in Q1 2025, and up 50.0% on a QoQ basis from $42000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $63000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 6200.0% year-over-year to $63000.0 in Q1 2026; TTM through Mar 2026 was $111000.0, a 2120.0% increase from a year earlier, with the FY2025 full-year figure at $70000.0, up 1300.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $63000.0, up from $42000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for NRXP reached as high as $63000.0 in Q1 2026 and fell as low as -$20000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $7411.8 across 5 years, with a median of $1000.0 in 2022.
- Across the five-year window, Depreciation & Amortization (CF) tumbled 2100.0% in 2025 and surged 6200.0% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then surged by 4100.0% to $42000.0 in 2025, then soared by 50.0% to $63000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $63000.0 in Q1 2026, $42000.0 in Q4 2025, and $26000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |